Narrow Your Results
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2016)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2016)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2016)]. The objective of this test specification is to provide a...
This document specifies requirements for sterile single-use hypodermic syringes of nominal capacity 1 ml and above, made of plastic materials and intended for use with power-driven syringe pumps. This document does not apply to syringes with auto-disable syringe features (ISO 7886-3[2]),...
This document specifies requirements for sterile single-use hypodermic syringes of nominal capacity 1 ml and above, made of plastic materials and intended for use with power-driven syringe pumps. This document does not apply to syringes for use with insulin (specified in ISO 8537[2]),...
This document specifies requirements for sterile single-use hypodermic syringes of nominal capacity 1 ml and above, made of plastic materials and intended for use with power-driven syringe pumps. This document does not apply to syringes for use with insulin (specified in ISO 8537[2]),...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2017)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2017)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices (PHD) interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2017)]. The objective of this test specification is to...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2016)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2017)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes TPs) for the Personal Health Devices interface based on the requirements defined in Continua Design Guidelines (CDG) [ITU-T H.810 (2017)]. The objective of this test specification is to provide a high...
This document specifies requirements for sterile single-use hypodermic syringes of nominal capacity 1 ml and above, made of plastic materials and intended for use with power-driven syringe pumps. This document does not apply to syringes with auto-disable syringe features (ISO 7886-3[2]),...
This document specifies requirements for sterile single-use hypodermic syringes of nominal capacity 1 ml and above, made of plastic materials and intended for use with power-driven syringe pumps. This document does not apply to syringes with auto-disable syringe features (ISO 7886-3[2]),...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2017)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TPs) for the Personal Health Devices (PHD) interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2017)]. The objective of this test specification is to...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2017)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2016)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2016)]. The objective of this test specification is to provide a...
The scope of this Recommendation1 is to provide a test suite structure (TSS) and the test purposes (TP) for the Personal Health Devices interface based on the requirements defined in the Continua Design Guidelines (CDG) [ITU-T H.810 (2016)]. The objective of this test specification is to provide a...
